Cardiovascular Drugs Market, by Drug Class (Anti-Hyperlipidemics, Anti-Hypertensive, Anti-Coagulants, Anti-Arrhythmic, Anti-Fibrinolytic, and Others {Cardiac Glycosides, Anti-Ischemic Drugs, and Antianginal Drugs}), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Regional segmentation of the cardiovascular drugs market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Africa, and Middle East.